Cargando…
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
Anti-angiogenesis therapy, a promising strategy against cancer progression, is limited by drug-resistance, which could be attributed to changes within the tumor microenvironment. Studies have increasingly shown that combining anti-angiogenesis drugs with immunotherapy synergistically inhibits tumor...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905241/ https://www.ncbi.nlm.nih.gov/pubmed/35281003 http://dx.doi.org/10.3389/fimmu.2022.802846 |